New Praxis test provides pharmacogenetic information

HUNTSVILLE, Ala. — Kailos Genetics, a personalized medicine information company offering gene-based testing, has announced the launch of Praxis, an accessible and affordable gene-based test that any adult can directly order and pay for online. 

 

The initial Praxis offering includes genetic testing to help people who are starting new medicines. Praxis will tell these individuals how their bodies metabolize certain drugs and provide information about their genes to help them work with their physicians to choose the best treatment plan. The pharmacogenetic information provided by the Praxis test can help determine if certain medications may not work as intended, or at all. Pricing ranges between $149 and $299.

 

“Healthcare should be about the individual, not about groups or populations. We believe that, to improve healthcare, everyone should have access to information about their own genes,” Brian Pollock, president and CEO of Kailos Genetics, said. “By combining precise and affordable gene-based testing with the right education and guidance to support the results, we aim to equip each person and their physician with the tools they need to lead happier, healthier lives.”

 

“Health information is power,” Troy Moore, chief scientific officer of Kailos Genetics, said. “The Praxis test gives people the ability to prepare for the future, empowering them and their care team to best manage their health.”

 

Future Praxis test offerings in development include additional pharmacogenetic selections, carrier screening for couples planning families and risk screening for diseases such as glaucoma and cancer, and medical conditions like high cholesterol.